TAMs could be recruited to tumor site by an interaction between CCL2 (constitutively produced by glioma cells) and its receptor CCR2 (expressed on TAMs) [226,232], what confirms the importance of chemokines as the key players in GBM progression. This evidence concerns the gene CCL2 and neoplasm.